Weekly HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Ratings as of Jun 27, 2018

June 27, 2018 - By Heather Owens

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Corporate Logo

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Ratings Coverage

Total analysts of 2 have positions in HTG Molecular Diagnostics (NASDAQ:HTGM) as follows: 2 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. Since January 5, 2018 according to StockzIntelligence Inc HTG Molecular Diagnostics has 11 analyst reports. On Monday, January 8 Canaccord Genuity maintained HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) with “Buy” rating. On Tuesday, April 17 the firm has “Buy” rating given by H.C. Wainwright. The stock rating was maintained by H.C. Wainwright with “Buy” on Friday, June 8. On Friday, March 23 H.C. Wainwright maintained the shares of HTGM in report with “Buy” rating. On Friday, January 5 H.C. Wainwright maintained HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) rating. H.C. Wainwright has “Buy” rating and $6.0 target. On Friday, January 5 the stock of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) earned “Buy” rating by Canaccord Genuity. On Tuesday, May 8 H.C. Wainwright maintained HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) rating. H.C. Wainwright has “Buy” rating and $700 target. In Friday, March 23 report Canaccord Genuity maintained it with “Buy” rating and $7 target. On Wednesday, January 24 H.C. Wainwright maintained HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) with “Buy” rating. On Tuesday, May 22 the stock of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) earned “Buy” rating by H.C. Wainwright. Listed here are HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) PTs and latest ratings.

08/06/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
22/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
08/05/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
17/04/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
23/03/2018 Broker: Canaccord Genuity Old Rating: Buy New Rating: Buy Old Target: $5 New Target: $7 Maintain
23/03/2018 Broker: H.C. Wainwright Rating: Buy New Target: $7.0000 Maintain
01/02/2018 Broker: H.C. Wainwright Rating: Buy New Target: $6.0 Maintain
24/01/2018 Broker: H.C. Wainwright Rating: Buy New Target: $6.0 Maintain
08/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $5.0 Maintain
05/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $5.0 Maintain

The stock decreased 1.63% or $0.055 during the last trading session, hitting $3.325.Currently HTG Molecular Diagnostics, Inc. is uptrending after 3.13% change in last June 27, 2017. HTGM has also 149,326 shares volume. HTGM underperformed by 9.44% the S&P500.

HTG Molecular Diagnostics, Inc. develops and markets services and products based on proprietary technology that facilitates the routine use of targeted molecular profiling.The firm is valued at $94.33 million. The companyÂ’s products, HTG Edge and HTG EdgeSeq platforms include instrumentation , consumables comprising assay kits, and software analytics that automate sample processing and profiles various molecular targets from samples a fraction of the size required by prevailing technologies.Last it reported negative earnings. The Company’s platforms generate a molecular profiling library for detection using next-generation sequencing.

There’s a substantial HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) news released by Seekingalpha.com. It’s an item titled: “HTG Molecular: Entering Stage Of Growth And Momentum” on June 11, 2018.

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.